Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $1.5 million.

  • Insight Molecular Diagnostics' Other Non-Current Assets fell 1176.47% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 1176.47%. This contributed to the annual value of $1.7 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Other Non-Current Assets is $1.5 million, which was down 1176.47% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Other Non-Current Assets registered a high of $29.7 million during Q4 2021, and its lowest value of $1.5 million during Q3 2025.
  • Moreover, its 5-year median value for Other Non-Current Assets was $1.7 million (2021), whereas its average is $3.4 million.
  • In the last 5 years, Insight Molecular Diagnostics' Other Non-Current Assets surged by 164600.0% in 2021 and then tumbled by 9285.43% in 2022.
  • Insight Molecular Diagnostics' Other Non-Current Assets (Quarter) stood at $29.7 million in 2021, then plummeted by 92.85% to $2.1 million in 2022, then fell by 19.85% to $1.7 million in 2023, then changed by 0.0% to $1.7 million in 2024, then fell by 11.76% to $1.5 million in 2025.
  • Its Other Non-Current Assets stands at $1.5 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.